124 results on '"Libe, Rossella"'
Search Results
2. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
3. Recommandations du réseau national ENDOCAN-COMETE pour la prise en charge des phéochromocytomes et paragangliomes métastatiques
4. Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE
5. Recommandations conjointes du réseau National ENDOCAN-COMETE, de l’Association francophone de chirurgie endocrinienne et de la Société française d’urologie pour la prise en charge du carcinome corticosurrénalien
6. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease
7. KDM1A inactivation causes hereditary food-dependent Cushing syndrome
8. Effectiveness of temozolomide treatment in SDHx mutant and wildtype metastatic pheochromocytoma and paraganglioma - results of a European restrospective multicentre study
9. Decrease in anticortisolic drmg osilodrostat plasma exposure in patients treated with mitotane for adrenocortical carcinoma
10. Medical management of adrenocortical carcinoma: Current recommendations, new therapeutic options and future perspectives
11. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
12. Adrenocortical Cancer
13. Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation
14. Artistic movements as pitfalls in iconodiagnosis
15. Decrease in anticortisolic drug osilodrostat plasma exposure in patients treated with mitotane for an adrenocortical carcinoma
16. Whole blood transcriptomic signature of Cushing's syndrome
17. Tumor microenvironment of adrenocortical carcinoma dissected by single-cell RNA-sequencing
18. Prolonged exposure to target mitotane concentrations is associated with better recurrence-free survival in patients with adrenocortical carcinoma on adjuvant treatment
19. C-peptide level concomitant with hypoglycemia gives better performances than insulin for the diagnosis of endogenous hyperinsulinism: a monocentric study of 159 fasting trials
20. Corticosurrénalome et grossesse
21. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
22. Data from Functional Phosphodiesterase 11A Mutations May Modify the Risk of Familial and Bilateral Testicular Germ Cell Tumors
23. Supplementary Table 1 from Functional Phosphodiesterase 11A Mutations May Modify the Risk of Familial and Bilateral Testicular Germ Cell Tumors
24. Supplementary Table 2 from Functional Phosphodiesterase 11A Mutations May Modify the Risk of Familial and Bilateral Testicular Germ Cell Tumors
25. Thyroid swellings in Renaissance illuminations
26. Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
27. Rasch analysis for assessing unidimensionality and identifying measurement biases of malignancy scores in oncology. The example of the Weiss histopathological system for the diagnosis of adrenocortical cancer
28. Corticosurrénalome : nouveautés en 2014
29. Adrenocortical Cancer
30. Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma
31. Integrated genomics reveals the molecular classification of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH), correlating with specific profiles of illegitimate receptors expression and identifies KDM1A as the genetic cause of food-dependent Cushing syndrome
32. Positive Correlation Between [18F]-fluorodeoxyglucose (FDG) Uptake and Tumor-proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas
33. Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging
34. Le corticosurrénalome : progrès dans la physiopathologie et la prise en charge d’un cancer rare
35. Pre-operative hypercortisolism and post-operative adrenal insufficiency in pheochromocytomas: a single center retrospective analysis of 168 patients
36. PDE11A4 (Phosphodiesterase 11 A4) is a modulator of the primary bilateral macronodular adrenal hyperplasia (PBMAH) phenotype: genotype/phenotype analysis of a cohort of 354 patients analysed by next-generation sequencing (NGS)
37. Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
38. Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
39. Paracrine Regulation of Cortisol Secretion by Serotonin (5-HT) Involving Illegitimate Membrane Receptors in Primary Pigmented Nodular Adrenal Disease (PPNAD)
40. Steroid Profiling in Adrenocortical Carcinoma Reveals Mitotane as a Strong Inducer of CYP3A4 and Inhibitor of 5α-Reductase with Major Implications for Cortisol and Androgen Metabolism
41. Adrenocortical Cancer
42. Identification of transcriptome profiles in paraffin samples using 3’ RNA-sequencing for the prognostic assessment of adrenocortical carcinoma
43. Identification of clinical parameters predictive of ARMC5 mutation in a large cohort of primary bilateral macronodular adrenal hyperplasia (PBMAH) patients.
44. Letter to the Editor from Berthon: “Cardiac Myxoma Caused by Fumarate Hydratase Gene Deletion in Patient With Cortisol-Secreting Adrenocortical Adenoma”
45. Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma
46. Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease
47. Contribution of morphological and functional liver imaging to differentiate liver metastases of adrenocortical carcinoma from those of neuroendocrine tumors in a woman with a final diagnosis of multiple endocrine neoplasia type 1
48. Molecular events in a large series of advanced stage III-IV adrenocortical cancer: looking for new therapeutic options
49. The French COMETE-Cancer network for adrenal cancer: 10 years of activity as part of a national plan for clinical care of rare cancers
50. Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (glucocorticoid receptor) and PDE11A4 (phosphodiesterase 11) in 389 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.